Literature DB >> 11895986

Balance of pro- and anti-inflammatory cytokines correlates with outcome of acute experimental Pseudomonas aeruginosa keratitis.

A Thakur1, M Xue, F Stapleton, A R Lloyd, D Wakefield, M D P Willcox.   

Abstract

The purpose of this study was to elucidate the expression of pro- and anti-inflammatory cytokines in mouse corneas infected with Pseudomonas aeruginosa. Three bacterial strains (invasive, cytotoxic, or CLARE [contact lens-induced acute red eye]) which have recently been shown to produce distinct patterns of corneal disease in the mouse were used. The left mouse (BALB/c) corneas were scarified and infected with 2 x 10(6) CFU of one of the three P. aeruginosa strains, while right eyes served as controls. Animals were examined at 1, 4, 8, 16, and 24 h with a slit lamp biomicroscope to grade the severity of infection. Following examination, eyes were collected and processed for histopathology, multiprobe RNase protection assay for cytokine mRNA, enzyme-linked immunosorbent assay to quantitate cytokine proteins, and myeloperoxidase activity to quantitate polymorphonuclear leukocytes. The kinetics of appearance and magnitude of expression of key cytokines varied significantly in the three different phenotypes of P. aeruginosa infection. The predominant cytokines expressed in response to all three phenotypes were interleukin-1 beta (IL-1 beta), IL-1Ra, and IL-6. In response to the invasive strain, which induced severe corneal inflammation, significantly lower ratios of IL-1Ra to IL-1 beta were present at all time points, whereas corneas challenged with the CLARE strain, which induced very mild inflammation, showed a high ratio of IL-1Ra to IL-1 beta. The outcome of infection in bacterial keratitis correlated with the relative induction of these pro- and anti-inflammatory cytokines, and exogenous administration of recombinant rIL-1Ra (rIL-1Ra) was able to reduce the disease severity significantly. These findings point to the therapeutic potential of rIL-1Ra protein in possible treatment strategies for bacterial keratitis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11895986      PMCID: PMC127830          DOI: 10.1128/IAI.70.4.2187-2197.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  58 in total

1.  An NF-kappa B-like transcription factor mediates IL-1/TNF-alpha induction of gro in human fibroblasts.

Authors:  A Anisowicz; M Messineo; S W Lee; R Sager
Journal:  J Immunol       Date:  1991-07-15       Impact factor: 5.422

2.  CD40 engagement modulates the production of matrix metalloproteinases by gingival fibroblasts.

Authors:  A Wassenaar; T Verschoor; F Kievits; M T Den Hartog; M L Kapsenberg; V Everts; A Snijders
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

Review 3.  Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF).

Authors:  S Akira; T Hirano; T Taga; T Kishimoto
Journal:  FASEB J       Date:  1990-08       Impact factor: 5.191

4.  Post-transcriptional regulation of gro alpha, beta, gamma, and IL-8 mRNAs by IL-1 beta.

Authors:  M Y Stoeckle
Journal:  Nucleic Acids Res       Date:  1991-02-25       Impact factor: 16.971

5.  IL-1 receptor antagonist regulation of acute phase protein synthesis in human hepatoma cells.

Authors:  S Bevan; J G Raynes
Journal:  J Immunol       Date:  1991-10-15       Impact factor: 5.422

6.  Interleukin-1 receptor antagonist reduces mortality from endotoxin shock.

Authors:  K Ohlsson; P Björk; M Bergenfeldt; R Hageman; R C Thompson
Journal:  Nature       Date:  1990-12-06       Impact factor: 49.962

7.  Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55.

Authors:  H Tilg; E Trehu; M B Atkins; C A Dinarello; J W Mier
Journal:  Blood       Date:  1994-01-01       Impact factor: 22.113

8.  Balance of synovial fluid IL-1 beta and IL-1 receptor antagonist and recovery from Lyme arthritis.

Authors:  L C Miller; E A Lynch; S Isa; J W Logan; C A Dinarello; A C Steere
Journal:  Lancet       Date:  1993-01-16       Impact factor: 79.321

9.  Transforming growth factor-beta and interleukin-1 modulate metalloproteinase expression by corneal stromal cells.

Authors:  M T Girard; M Matsubara; M E Fini
Journal:  Invest Ophthalmol Vis Sci       Date:  1991-08       Impact factor: 4.799

10.  Differential expression of human corneal and perilimbal ICAM-1 by inflammatory cytokines.

Authors:  M A Pavilack; V M Elner; S G Elner; R F Todd; A R Huber
Journal:  Invest Ophthalmol Vis Sci       Date:  1992-03       Impact factor: 4.799

View more
  21 in total

1.  Corneal stromal cells selectively inhibit production of anti-inflammatory cytokines by activated T cells.

Authors:  V Holán; A Vítová; J Pindjáková; M Krulová; A Zajícová; M Filipec
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

2.  Genomic and transcriptional Profiling of tumor infiltrated CD8+ T cells revealed functional heterogeneity of antitumor immunity in hepatocellular carcinoma.

Authors:  Zhenli Li; Geng Chen; Zhixiong Cai; Xiuqing Dong; Liman Qiu; Haipo Xu; Yongyi Zeng; Xiaolong Liu; Jingfeng Liu
Journal:  Oncoimmunology       Date:  2018-11-10       Impact factor: 8.110

Review 3.  Inflammasomes, the eye and anti-inflammasome therapy.

Authors:  P Yerramothu; A K Vijay; M D P Willcox
Journal:  Eye (Lond)       Date:  2017-11-24       Impact factor: 3.775

4.  A predominantly anti-inflammatory cytokine profile is associated with disease severity in meningococcal sepsis.

Authors:  Enitan D Carrol; Alistair P J Thomson; Ashley P Jones; Graham Jeffers; C Anthony Hart
Journal:  Intensive Care Med       Date:  2005-08-27       Impact factor: 17.440

5.  Ocular Glands Become Infected Secondarily to Infectious Keratitis and Play a Role in Corneal Resistance to Infection.

Authors:  Micaela L Montgomery; Michelle C Callegan; Kevin K Fuller; Daniel J J Carr
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

6.  Tacrolimus Loaded PEG-Cholecalciferol Based Micelles for Treatment of Ocular Inflammation.

Authors:  Shallu Kutlehria; Imran Vhora; Arvind Bagde; Nusrat Chowdhury; Gautam Behl; Ketan Patel; Mandip Singh
Journal:  Pharm Res       Date:  2018-04-16       Impact factor: 4.200

7.  Inhibition of macrophage migration inhibitory factor ameliorates ocular Pseudomonas aeruginosa-induced keratitis.

Authors:  Mihaela Gadjeva; Jill Nagashima; Tanweer Zaidi; Robert A Mitchell; Gerald B Pier
Journal:  PLoS Pathog       Date:  2010-03-26       Impact factor: 6.823

8.  Cathelicidin-deficient (Cnlp -/- ) mice show increased susceptibility to Pseudomonas aeruginosa keratitis.

Authors:  Ling C Huang; Rose Y Reins; Richard L Gallo; Alison M McDermott
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-10       Impact factor: 4.799

9.  Antimicrobial efficacy and ocular cell toxicity from silver nanoparticles.

Authors:  Colleen M Santoro; Nicole L Duchsherer; David W Grainger
Journal:  Nanobiotechnology       Date:  2007-05-01

10.  Role of neutrophils, MyD88-mediated neutrophil recruitment, and complement in antibody-mediated defense against Pseudomonas aeruginosa keratitis.

Authors:  Tanweer S Zaidi; Tauqeer Zaidi; Gerald B Pier
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-11-05       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.